Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2019

01-01-2019 | Editorial

Big Sleep: Beyond Propofol Sedation During GI Endoscopy

Author: Basavana Goudra

Published in: Digestive Diseases and Sciences | Issue 1/2019

Login to get access

Excerpt

In the USA, endoscopic procedures are usually performed on sedated patients, which improves overall patient acceptance and comfort while improving procedural safety, efficiency, and quality [1]. A range of sedation depth is available, from moderate sedation on the one hand to general anesthesia on the other. Although during general anesthesia patients are not arousable even by painful stimulation, moderate sedation (“conscious sedation”) is characterized by depression of consciousness during which patients respond purposefully to verbal commands, either alone or accompanied by light tactile stimulation. At least in the USA, deep sedation is preferred by both patients and their gastroenterologists. …
Literature
1.
go back to reference Müller M, Wehrmann T. How best to approach endoscopic sedation? Nat Rev Gastroenterol Hepatol. 2011;8:481–490.CrossRef Müller M, Wehrmann T. How best to approach endoscopic sedation? Nat Rev Gastroenterol Hepatol. 2011;8:481–490.CrossRef
2.
go back to reference Blayney MR. Procedural sedation for adult patients: an overview. Contin Educ Anaesth Crit Care Pain. 2012;12:176–180.CrossRef Blayney MR. Procedural sedation for adult patients: an overview. Contin Educ Anaesth Crit Care Pain. 2012;12:176–180.CrossRef
3.
go back to reference Goudra B, Singh PM, Gouda G, Borle A, Carlin A, Yadwad A. Propofol and non-propofol based sedation for outpatient colonoscopy-prospective comparison of depth of sedation using an EEG based SEDLine monitor. J Clin Monit Comput. 2015;30:551–557.CrossRef Goudra B, Singh PM, Gouda G, Borle A, Carlin A, Yadwad A. Propofol and non-propofol based sedation for outpatient colonoscopy-prospective comparison of depth of sedation using an EEG based SEDLine monitor. J Clin Monit Comput. 2015;30:551–557.CrossRef
4.
go back to reference Wernli KJ, Brenner AT, Rutter CM, Inadomi JM. Risks associated with anesthesia services during colonoscopy. Gastroenterology. 2016;150:888–894; quiz e18. Wernli KJ, Brenner AT, Rutter CM, Inadomi JM. Risks associated with anesthesia services during colonoscopy. Gastroenterology. 2016;150:888–894; quiz e18.
5.
go back to reference Bielawska B, Hookey LC, Sutradhar R, et al. Anesthesia assistance in outpatient colonoscopy and risk of aspiration pneumonia, bowel perforation, and splenic injury. Gastroenterology. 2018;154:77–85.e3. Bielawska B, Hookey LC, Sutradhar R, et al. Anesthesia assistance in outpatient colonoscopy and risk of aspiration pneumonia, bowel perforation, and splenic injury. Gastroenterology. 2018;154:77–85.e3.
6.
go back to reference Goudra BG, Singh PM, Gouda G, et al. Safety of non-anesthesia provider-administered propofol (NAAP) sedation in advanced gastrointestinal endoscopic procedures: comparative meta-analysis of pooled results. Dig Dis Sci. 2015;60:2612–2627.CrossRef Goudra BG, Singh PM, Gouda G, et al. Safety of non-anesthesia provider-administered propofol (NAAP) sedation in advanced gastrointestinal endoscopic procedures: comparative meta-analysis of pooled results. Dig Dis Sci. 2015;60:2612–2627.CrossRef
7.
go back to reference Thompson Bastin ML, Baker SN, Weant KA. Effects of etomidate on adrenal suppression: a review of intubated septic patients. Hosp Pharm. 2014;49:177–183.CrossRef Thompson Bastin ML, Baker SN, Weant KA. Effects of etomidate on adrenal suppression: a review of intubated septic patients. Hosp Pharm. 2014;49:177–183.CrossRef
8.
go back to reference Kim MG, Park SW, Kim JH, et al. Etomidate versus propofol sedation for complex upper endoscopic procedures: a prospective double-blinded randomized controlled trial. Gastrointestinal Endoscopy. 2017;86:452–461.CrossRef Kim MG, Park SW, Kim JH, et al. Etomidate versus propofol sedation for complex upper endoscopic procedures: a prospective double-blinded randomized controlled trial. Gastrointestinal Endoscopy. 2017;86:452–461.CrossRef
10.
go back to reference Goudra BG, Singh PM. Propofol alternatives in gastrointestinal endoscopy anesthesia. Saudi J Anaesth. 2014;8:540–545.CrossRef Goudra BG, Singh PM. Propofol alternatives in gastrointestinal endoscopy anesthesia. Saudi J Anaesth. 2014;8:540–545.CrossRef
11.
go back to reference Amornyotin S. Sedation and monitoring for gastrointestinal endoscopy. World J Gastrointest Endosc. 2013;5:47–55.CrossRef Amornyotin S. Sedation and monitoring for gastrointestinal endoscopy. World J Gastrointest Endosc. 2013;5:47–55.CrossRef
12.
go back to reference Amornyotin S. Dexmedetomidine in gastrointestinal endoscopic procedures. World J Anesthesiol. 2016;5:1–14.CrossRef Amornyotin S. Dexmedetomidine in gastrointestinal endoscopic procedures. World J Anesthesiol. 2016;5:1–14.CrossRef
Metadata
Title
Big Sleep: Beyond Propofol Sedation During GI Endoscopy
Author
Basavana Goudra
Publication date
01-01-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5287-x

Other articles of this Issue 1/2019

Digestive Diseases and Sciences 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine